The possible mechanism of insulin resistance in NAFLD is that increased hepatic insulin and impaired glucose are involved in hepatic de novo lipogenesis, which activate sterol regulatory element-binding protein 1c (SREBP-1c) and carbohydrate response element-binding protein (ChREBP), respectively. The gene discussed is MLXIPL; the disease is metabolic dysfunction-associated steatotic liver disease.